Indian biotech firm Biocon ranked among world's top 10
A recent report released by Med Ad News ranked Biocon (Bangalore, Karnataka), India's pioneer in the biotechnology sector, among the world's top 25 biotechnology companies. The report, which listed drug-based firms by revenue and by income, ranked Biocon at 20, reports Industrial Info Resources.
Biocon has the distinction of being the only Asian company to be featured in the league, which includes 19 US companies and five others from Europe and Australia.
Firms from across the world have begun to take interest in India's biotechnology industry, including Eli Lilly and Sigma-Aldrich. US health care major Johnson & Johnson and Switzerland's Novartis are among several major companies that already have a presence in the country (Marketletters passim).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze